The U.S. Food and Drug Administration has approved an expanded indication for Eli Lilly's Jaypirca (pirtobrutinib), the first and only noncovalent Bruton tyrosine kinase (BTK) inhibitor for adults ...
Crohn disease is a chronic inflammatory bowel disease that requires long-term medical and surgical management to improve quality of life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback